CATX•benzinga•
Perspective Therapeutics Doses First Patient With [212Pb]VMT01 Monotherapy At 1.5 mCi In Phase 1/2a Study Of MC1R-Positive Metastatic Melanoma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 11, 2025 by benzinga